NeuroOne Medical Technologies (NMTC) 10-K2023 FY Annual report

Filed: 15 Dec 23, 4:39pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: addressable, ATM, banking, Benchmark, Bingaman, biopharma, biotech, book, borrow, center, Christopher, consecutive, crime, dollar, East, email, Equiniti, exploit, gene, instability, invivo, leg, lingering, lumen, Middle, nil, recession, recovery, restore, robotic, Russia, slightly, slowdown, stemming, subheading, summative, surrendered, tightening, usability, victim, Volker, William, withholding

Removed: absenteeism, accredited, adjustment, amending, amounting, announcement, annum, award, biocompatibility, BIP, Biynah, Christianson, clarifying, combat, comprehensively, conspiracy, consummated, converted, CSF, customary, discounted, distancing, district, divided, duty, Edenvale, embedded, enriched, equaling, evidenced, executed, Exhibit, faith, feature, fiduciary, forgivable, forgiven, Fredrickson, ill, implementation, indefinite, indemnification, infected, interfered, loan, mandated, Mark, mortgage, multiplied, nominal, optional, owner, Paulson, paycheck, personal, PPP, preventative, promissory, promptly, protective, range, ranged, recapitalization, redemption, referenced, reoccur, reorganization, repay, representing, revaluation, simplify, split, staffing, streamline, subscriber, subscription, tortiously, travel, turnover, unjustly, unpaid, unregistered, validation, virtue, Wade

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated NMTC transcripts

NMTC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File No. 333-232656, 333-244487, 333-252951), Form S-3 (File No. 333-256830) and Form S-8 (File No. 333-224572, 333-261302, 333-262397, 333-269910) of NeuroOne Medical Technologies Corporation of our report dated December 15, 2023, relating to the financial statements, which report expresses an unqualified opinion to the financial statements for the year ended September 30, 2023 and includes an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 2 to the financial statements, appearing herein.

/s/ Baker Tilly US, LLP

Minneapolis, Minnesota

December 15, 2023